F.W. Korsten

500 total citations
7 papers, 394 citations indexed

About

F.W. Korsten is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F.W. Korsten has authored 7 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F.W. Korsten's work include Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). F.W. Korsten is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). F.W. Korsten collaborates with scholars based in Germany, Switzerland and Netherlands. F.W. Korsten's co-authors include H. E. Reis, Serge Leyvraz, Harry Bleiberg, T. Conroy, Marc Buyse, H. O. Klein, M. Fickers, J. Wils, D. J. Th. Wagener and Manfred Kindler and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Molecular Medicine.

In The Last Decade

F.W. Korsten

7 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.W. Korsten Germany 5 297 249 143 87 29 7 394
Yuichi Kasakura Japan 10 347 1.2× 132 0.5× 217 1.5× 145 1.7× 15 0.5× 24 443
Toshiaki Yasui Japan 5 252 0.8× 83 0.3× 214 1.5× 133 1.5× 19 0.7× 12 375
Hyung Geun Lee South Korea 9 236 0.8× 341 1.4× 334 2.3× 56 0.6× 16 0.6× 11 435
Takayoshi Akiyama Japan 10 191 0.6× 147 0.6× 238 1.7× 51 0.6× 34 1.2× 38 355
Nobuyuki Ehira Japan 12 388 1.3× 238 1.0× 372 2.6× 57 0.7× 13 0.4× 19 507
Takayoshi Noguchi Japan 7 181 0.6× 75 0.3× 149 1.0× 87 1.0× 30 1.0× 21 312
Udo Lindig Germany 10 210 0.7× 181 0.7× 134 0.9× 83 1.0× 31 1.1× 36 298
Marcelo Cury Brazil 6 168 0.6× 299 1.2× 211 1.5× 26 0.3× 20 0.7× 18 352
Toshiaki Nakatsu Japan 12 341 1.1× 208 0.8× 366 2.6× 40 0.5× 14 0.5× 29 440
Anne Thirot‐Bidault France 9 191 0.6× 243 1.0× 183 1.3× 104 1.2× 48 1.7× 20 374

Countries citing papers authored by F.W. Korsten

Since Specialization
Citations

This map shows the geographic impact of F.W. Korsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.W. Korsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.W. Korsten more than expected).

Fields of papers citing papers by F.W. Korsten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.W. Korsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.W. Korsten. The network helps show where F.W. Korsten may publish in the future.

Co-authorship network of co-authors of F.W. Korsten

This figure shows the co-authorship network connecting the top 25 collaborators of F.W. Korsten. A scholar is included among the top collaborators of F.W. Korsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.W. Korsten. F.W. Korsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pelzer, Uwe, Dirk Arnold, P Reitzig, et al.. (2011). First-line treatment of pancreatic cancer patients with the combination of 5-fluorouracil/folinic acid plus gemcitabine: a multicenter phase II trial by the CONKO-study group. Cancer Chemotherapy and Pharmacology. 68(5). 1173–1178. 5 indexed citations
2.
Oettle, Helmut, M. Arning, Uwe Pelzer, et al.. (2000). A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer. Annals of Oncology. 11(10). 1267–1272. 43 indexed citations
3.
Löffler, Thomas, F.W. Korsten, M. Planker, et al.. (1992). Fluorouracil als Monotherapie oder in Kombination mit Folinsäure in der Behandlung des metastasierten kolorektalen Karzinoms. DMW - Deutsche Medizinische Wochenschrift. 117(26). 1007–1013. 15 indexed citations
4.
Herrmann, Richard, et al.. (1992). Sequential methotrexate and 5-fluorouracil (FU) vs. FU alone in metastatic colorectal cancer. Annals of Oncology. 3(7). 539–543. 15 indexed citations
6.
Reis, H. E. & F.W. Korsten. (1985). A Modified Sclerosing Needle for the Sclerotherapy of Upper Gastrointestinal Bleeding. Endoscopy. 17(6). 221–223. 2 indexed citations
7.
Purrmann, J, et al.. (1985). Zur Genetik des Morbus Crohn: Untersuchung der HLA-Assoziation bei 169 Patienten. Journal of Molecular Medicine. 63(16). 747–751. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026